Genç TRASD

🔎 Minimal important differences of measurement instruments used in rheumatoid arthritis: a scoping review 📊 Most common: HAQ-DI, physical function, disease activity 💡 Highlights variability in MIDs—crucial for clinical decisions! @BioMedCentral #RA 👉 bmcrheumatol.biomedcentral.com/articles/10.11…

Monitoring disease activity and treatment response in ankylosing spondylitis: a retrospective study of hematologic inflammatory markers @NeslihanGken7 @goksu_kemer @abdulvahap_md @Gulsandaluzun @hande_snc @ahmetusen @ahmetak20160685 @GencTRASD pubmed.ncbi.nlm.nih.gov/39733134/

📌 A comprehensive and insightful treatment schema for Rheumatoid Arthritis @Nature @NaturePortfolio 👉 nature.com/articles/s4158…

NATURE 2025: Prediabetes doi.org/10.1038/s41572… #MedEd #MedTwitter #MedX

🎯 A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis @Nature @NaturePortfolio 👉 nature.com/articles/s4146…

Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity @ASAS @hande_snc @abdulvahap_md @dr_ismihan @GencTRASD @ArLARheumatolog pmc.ncbi.nlm.nih.gov/articles/PMC10…

💥 Association of Abatacept with Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial @ACRheum 👉 acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

Great news!! Our paper with the results of our Living With SLE in Europe: Swiss Knife Survey is out! Thanks @Lupusreference for your amazing support! Thanks also @sarahdyball1 @G_O_Daniel @cristianasieiro @elis_chessa @jeanette_lupus @ricky_chotai @tulupus @AnnemarieS66 et al!

✅ What is lacking the most at the #lupus consultation, from the #patient perspective? OPEN-ACCESS FREE LINK: sciencedirect.com/science/articl…

📢 Our new paper is out in Autoimmunity Reviews! We review how social determinants of health #SDH shape outcomes in #lupus — across the full patient journey — and explore solutions. Huge thank you to Zoe & Lena from @LupusEurope and @Lupusreference ! 🔗 doi.org/10.1016/j.autr…

🧠 A rare case + systematic review highlight CNS involvement in EGPA! 🩻 DSA uncovered critical cerebral artery stenosis missed by CTA/MRI. 📌 Angiography may play a key role in EGPA neurovascular evaluation @BioMedCentral #Vasculitis #EGPA 👉 bmcrheumatol.biomedcentral.com/articles/10.11…

🔬 New RCT in #RheumatoidArthritis shows: 4000 IU/day of Vitamin D for 6 months significantly reduced pain (VAS) & disease activity (DAS28) ☀️A promising adjunct in RA care—more long-term data needed! @BioMedCentral @wbgrant2 #VitaminD #RA 👉 bmcrheumatol.biomedcentral.com/articles/10.11…

Take the #EXPLOREPsA survey 🧭 — led by #YoungGRAPPA to learn how PsA disease activity is assessed globally. 🕐 5–10 min 🌍 Worldwide participation welcome 🔗app.onlinesurveys.jisc.ac.uk/s/oxford/explo… @GrappaO @reumacia @rheum_cat @Lupusreference

Registration for #ACR25 is open! Join us for time with your colleagues & the latest advancements/scientific breakthroughs in #rheum. Don’t delay—EARLY registration rates end August 21. Register → acr.tw/44pY0G8

Correct Use of Articles and Prepositions in Academic Writing ... @BurhanFatihKoy1 @NeslihanGken7 @Nellziade @prakashini_ @DDoskaliuk @YuliyaFedorchen @AAuanassova @KardumZeljka @AlnaimatFatima @UlianaPidvalna @GeorgievMD @LinaMladenova ncbi.nlm.nih.gov/pmc/articles/P…

🔁 Rituximab in RA: Long-Term Real-World Data 📊 94% 3-year retention rate 📉 Fluctuating DAS28 due to retreatment timing 💡 Effective but treat-to-target timing impacts patient well-being @BioMedCentral @eular_org 👉 bmcrheumatol.biomedcentral.com/articles/10.11…

📢 Real-World Safety of Anifrolumab in SLE 🧬 Confirms known AEs: URTI, bronchitis, HZV ⚠️ New signals: dyspnea, alopecia, migraine, chest pain 📅 Most AEs in first month of use @BioMedCentral @eular_org @LupusResearch @TheLupusForum #Lupus #Anifrolumab #SLE #Pharmacovigilance

PMR & GCA not assoc w/ increased mortality, Norway study of 274 isolated PMR (mean age 72 yrs) & 63 GCA (age 72 yrs) pts. After mean F/U 13.7 yrs 96% were deceased. Standardized mortality ratio was Not incr for PMR (0.97)or GCA (1.10), but men w/ PMR had , lower all-cause…

🧒💪 New international recommendations for treat-to-target in juvenile dermatomyositis (JDM)! ✅ Inactive disease as the main goal within 12 months 💊 Steroid tapering guided by immunomodulation @eular_ARD #Myositis 💥 sciencedirect.com/science/articl…

🚨 New meta-analysis: NT-proBNP shows strong potential as a biomarker for coronary artery lesions in Kawasaki disease! 🧬 area under the ROC 0.85, diagnostic OR 12. May aid early diagnosis & risk stratification @ArchofRheum #KawasakiDisease #Pediatrics 👉 archivesofrheumatology.org/full-text/1667